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ABSTRACT
This study presents the synthesis, characterization and antimicrobial activity of copper(II) complexes of some ortho-substituted
aniline Schiff bases (L1–L8). The Schiff bases and their respective copper(II) complexes were characterized by a combination of
elemental analysis, infrared and UV/Visible studies. The structures of the ligands were also confirmed from 1H- and 13C-NMR
spectral data. The infrared and electronic transition studies showed that the ligands are bidentate coordinating via the imine
nitrogen and the phenolic oxygen atoms in a planar configuration. Introduction of aqueous ammonia to the ethanolic solution
of L3/L4 and Cu(OAc)2.H2O aliquot yielded an ammonia-based complex due to the hydrolysis of the imine bond. The crystal
structure of the resulting complex indicated a square planar geometry. The copper(II) ion crystallizes in the monoclinic system
with a space group of P21/c having a = 10.9309, b = 4.85600, c = 17.7030, á = ã = 90 ° and â = 119.658 °. The geometry is slightly
distorted from planarity with O1-Cu1-N1 bond angles of 92.19 ° and 87.8 °. The Schiff base ligands and their respective
copper(II) complexes were screened for their in vitro antibacterial and antifungal activity against Escherichia coli ATCC® 8739™*,
Staphylococcus aureus subsp. aureus ATCC® 6538™*, Bacillus subtilis subsp. spizizenii ATCC® 6633™* and Candida albicans ATCC®
2091™*. The o-vanillin-based ligands exhibited higher activity than the salicylaldehyde derivatives which were virtually
non-active against the tested organisms.
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1. Introduction
The chemistry of Schiff base compounds has been studied
extensively. They have various applications as coordinating
ligands,1–6 as catalysts,7–9 in electrochemistry,10–11 and medicinal
values. Schiff bases possess antimicrobial 12–19 and anti-inflam-
matory activity.20 It has been discovered that the biological activity
of some Schiff base ligands became enhanced upon chelation
with metal ions.21–22 In some cases, however, the free ligands do
possess higher activity than the corresponding metal com-
plexes,17 an indication that activity does not depend solely on the
presence of metal ions but rather a synergistic effect of many
factors. Many Schiff base metal complexes have been prepared
and screened for their antimicrobial activity.
Ortho-hydroxysalicylaldimines possess N2O2 donor atoms
and consequently, form stable chelates with metal ions.15,21,23–24
The configuration of the chelate group in the four coordinate
complexes may be square-planar, tetrahedral, distorted tetrahedral
or distorted trigonal pyramidal with the metal atom at the apex.
These configurations depend primarily on the nature of the
metal atom and also on the magnitude and symmetry of the
ligand field.25 Many bis-(salicylaldimine)Cu(II) complexes
Cu(Sal.R)2, have been prepared and most of them are considered
to be square-planar.25,26 For (Sal.R)2, R being alkyl or aryl groups;
the square-planar configuration is stable, but when there is
considerable steric hindrance, the distortion from the planarity
may occur.
This study presents the synthesis, characterization and
antimicrobial activity of copper(II) complexes of some Schiff base
ligands (L1–L8) derived from 2-hydroxy-3-methoxybenzalde-
hyde (o-vanillin)/2-hydroxybenzaldehyde (salicylaldehyde)
and ortho-substituted anilines (R = Cl, Br, CH3 and OCH3). In
addition, the crystal structure of bis-(2-methoxy-6-imino)
methylphenol copper(II) complex, obtained from the hydrolysis
of the methyl and methoxyl derivatives of o-vanillin Schiff bases
in the presence of aqueous ammonia, is also discussed.
2. Materials and Methods
All the chemicals and reagents were of analytical grade and
used without further purification. The 1H- and 13C-NMR spectra
were recorded in CDCl3 with SiMe4 as internal standard on a
Bruker Avance NMR operating at 400 MHz. The mid-infrared
absorption frequencies (4000–700 cm–1) were recorded on a
PerkinElmer Spectrum 100 FT-IR equipped with universal atten-
uated total reflectance (ATR) accessory while the far-infrared
(700–30 cm–1) spectra were recorded in nujol mull on a
PerkinElmer Spectrum 400 FT-IR. The UV/Visible spectra were
obtained from PerkinElmer Lambda 25 spectrophotometer. The
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elemental analysis, CHN, was done on Vario MICRO V1.6.2
elemental analysen systeme GmbH while the percentage metal
content was determined on a PerkinElmer A Analyst atomic
absorption spectrometer. Molar conductivity measurement for
the complexes was done in DMF, using Az® 86555 pH/mV/
Cond./TDS/Temp. The melting points (uncorrected) of the com-
pounds were determined using the Galenkemp melting point
apparatus. The microorganisms were purchased from Micro-
biologics (Cape Town, South Africa).
2.1. Synthesis of the Schiff Base Ligands
The Schiff base ligands were synthesized according to the
general procedure in the literature27 by condensing o-vanillin
and salicylaldehyde with 2-chloroaniline, 2-bromoaniline,
2-methylaniline and 2-methoxyaniline, respectively, as presented
in Scheme 1. The synthesized ligands are designated as
ovan-2-cla, ovan-2-bra, ovan-2-tol, ovan-2-nis, sal-2-cla,
sal-2-bra, sal-2-tol and sal-2-nis, corresponding to ligands L1–L8.
2.1.1. Ligand L1 (ovan-2-cla)
1.522 g (10.00 mmol) of o-vanillin was refluxed with 0.91 mL
(10.00 mmol) of o-chloroaniline in ethanol for 2 h to obtain an
orange solution. The solution was concentrated under reduced
pressure, and an orange precipitate was obtained. The precipi-
tate was filtered under suction, washed with ethanol and
recrystallized from ethanol. It was dried over silica gel in a desic-
cator. Yield: 1.387 g (53 %); dH (400 MHz, CDCl3) 13.65(1H, s,
-OH); 8.68(1H, s, HC=N); 7.52(1H, d, J 7.6 Hz); 7.36(2H, m);
7.25(1H, t, J 8.4 Hz); 7.06(2H, t, J 8.7 Hz); 6.93(1H, t, J 8.0 Hz) and
3.98(3H, s, -OCH3). dC (400 MHz, CDCl3): 163.51(HC=N);
152.09(Ar-OCH3); 149.06(Ar-OH); 145.49(Ar-N=C); 130.68,
128.23, 128.11, 124.32, 119.04, 115.57(Ar-C) and 56.62(-OCH3);
(Found: C, 63.82; H, 4.55; N, 5.10 %. Cal. for C14H12NO2Cl: C,
64.27; H, 4.62; N, 5.35 %).
2.1.2. Ligand L2 (ovan-2-bra)
The procedure was the same as for ligand L1 using o-vanillin
and o-bromoaniline. An orange precipitate was obtained. Yield:
0.890 g (29 %); dH (400 MHz, CDCl3): 13.73(1H, s, -OH); 8.68(1H,
s, HC=N); 7.52(1H, d, J 7.5 Hz); 7.34(2H, m); 7.25(1H, t, J 8.4 Hz);
7.06(2H, t, J 8.5 Hz); 6.93(1H, t, J 7.8 Hz) and 3.98(3H, s, -OCH3).
dC (400 MHz, CDCl3): 163.24(HC=N); 152.02 (Ar-OCH3);
148.81(Ar-N=C); 145.27(Ar-OH); 130.68(Ar-Br); 128.27, 128.14,
124.30, 119.00, 115.44(Ar-C) and 56.51(-OCH3); (Found: C, 54.84;
H, 3.94; N, 4.47 %; Cal. for C14H12NO2Br: C, 54.87; H, 3.92; N,
4.57 %).
2.1.3. Ligand L3 (ovan-2-tol)
The procedure was the same as for ligand L1 using o-vanillin
and 2-methylaniline (o-toluidine). A yellow precipitate was
obtained. Yield: 1.148 g (48 %); dH (400 MHz, CDCl3): 13.85(1H,
s,-OH); 8.64(1H, s, HC=N); 7.31(2H, t, J 8.7 Hz); 7.23(1H, d, J
8.2 Hz); 7.18(1H, d, J 7.6 Hz); 7.05(2H, m); 6.93(1H, t, J 7.5 Hz );
3.99(3H, s, -OCH3) and 2.44(3H, s, -CH3). dC (400 MHz, CDCl3):
162.36(HC=N); 152.12(Ar-OCH 3 ); 148.96(Ar-N=C);
147.37(Ar-OH); 133.01(Ar-Br); 128.27, 128.14, 124.30, 119.00,
115.44(Ar-C), 56.57(-OCH3) and 18.66(-CH3); (Found: C, 74.11; H,
6.26; N, 5.68 %; Cal. for C15H15NO2: C, 74.66; H, 6.27; N, 5.80 %).
2.1.4. Ligand L4 (ovan-2-nis)
The procedure was the same as for ligand L1 using o-vanillin
and 2-methoxyaniline (o-anisidine). A red precipitate was
obtained. Yield: 2.30 g (89 %); dH (400 MHz, CDCl3): 14.42(1H,
s,-OH); 8.74(1H, s, HC=N); 7.27(2H, t, J 7.3 Hz); 7.20(1H, d, J
8.5 Hz); 7.15(1H, d, J 8.2 Hz); 7.05(2H, m); 6.93(1H, t, J 8.1 Hz);
3.97(3H, s,-OCH3); and 3.93(3H, s,-OCH3). dC (400 MHz, CDCl3):
161.77(HC=N); 153.49, 153.08(Ar-OCH3); 136.79 (Ar-N=C);
149.19(Ar-OH); 128.42, 123.95, 119.99, 118.40, 112.42,
110.90(Ar-C); 56.57, 56.28(-OCH3). Found: C, 69.35; H, 5.98; N,
5.30 %; Cal. for C15H15NO3: C, 70.02; H, 5.88; N, 5.44 %).
2.1.5. Ligand L5 (sal-2-cla)
The procedure was the same as for ligand L1 using
salicylaldehyde and 2-chloroaniline. A yellow precipitate was
obtained. Yield: 1.05 g, 45 %; dH (400 MHz, CDCl3): 13.21(1H,
s,-OH); 8.66(1H, s, HC=N); 7.75(1H, d, J 8.5 Hz ); 7.50(2H, t, J
8.2 Hz); 7.42(1H, d, J 8.0 Hz); 7.30(1H, d, J 7.4 Hz); 7.22(1H, t, J
7.8 Hz); 7.11(1H, d, J 8. 5 Hz); 7.00(1H, t, J 8.0 Hz). dC (400 MHz,
CDCl3): 163.74(Ar-OH); 161.81(HC=N); 145.86(Ar-N=C);
130.65(Ar-Cl); 134.11, 132.90, 129.95, 128.16, 128.12, 119.65, 119.54,
117.93(Ar-C); (Found: C, 66.97; H, 4.31; N, 6.00 %; Cal. for
C13H10NOCl: C, 67.39; H, 4.35; N, 6.05 %).
2.1.6. Ligand L6 (sal-2-bra)
The procedure was the same as for ligand L1 using
salicylaldehyde and 2-bromoaniline. A yellow precipitate was
obtained. Yield: 2.15 g (78 %); dH (400 MHz, CDCl3):
13.13(1H,s,-OH); 8.64(1H, s, HC=N); 7.71(1H, d, J 8.2 Hz);
7.45(2H, t, J 7.4 Hz); 7.39(1H, d, J 7. 8 Hz); 7.27(1H, d, J 8.1 Hz);
7.18(1H, t, J 7. 7 Hz); 7.09(1H, d, J 8.8 Hz); 6.99(1H, t, J 8.4 Hz).
dC (400 MHz, CDCl3): 163.64(Ar-OH); 161.73(HC=N);
147.26(Ar-C=N); 134.13, 132.94, 128.90, 128.39, 120.37, 119.57,
119.46, 117.94(Ar-C); (Found: C, 56.43; H, 3.56; N, 5.04 %; Cal. for
C13H10NOBr: C, 56.49; H, 3.62; N, 5.79 %).
2.1.7. Ligand L7 (sal-2-tol)
The procedure was the same as for ligand L1 using
salicylaldehyde and o-methylaniline (o-toluidine). Yield: 1.55 g
(73 %); dH (400 MHz, CDCl3): 13.48(1H, s, -OH); 8.62(1H, s,
HC=N); 7.44 (2H, m); 7.32(2H, t, J 8.6 Hz); 7.24(1H, d, J 8.8 Hz);
7.15(1H, d, J 7.6 Hz); 7.08(1H, d, J 8. 38 Hz); 6.99(1H, t, J 7. 8 Hz);
2.44(3H, s, -CH3). dC (400 MHz, CDCl3): 162.69 (Ar-OH); 161.65
(Ar-OCH3; Ar-N=C); 147.93(Ar-OH); 133.56(Ar-CH3); 132.77,
132.64, 131.15, 127.47, 127.30, 119.79, 119.48, 118.19, 117.66(Ar-C)
and 18.68(-CH3). (Found: C, 78.84; H, 6.19; N, 6.6 %); Cal. for
C14H13NO: C, 79.52; H, 6.15; N, 6.63 %.
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Scheme 1 Synthesis of the Schiff base ligands.
2.1.8. Ligand L8 (sal-2-nis)
The procedure was the same as for ligand L1 using
salicylaldehyde and o-methoxyaniline (o-anisidine). Yield:
1.395 g (61 %); dH (400 MHz, CDCl3): 13.41(1H, s, -OH); 8.64(1H,
s, HC=N); 7.38 (2H, m); 7.29(2H, t, J 7.80 Hz); 7.20(1H, d, J 8.2 Hz);
7.10(1H, d, J 8.2 Hz); 7.05(1H, d, J 8.4 Hz); 6.90(1H, t, J 8.0 Hz);
3.88(3H, s, -OCH3). dC (400 MHz, CDCl3): 162.54(Ar-OH);
162.02(HC=N); 153.40(Ar-OCH3); 137.55 (Ar-N=C); 133.32,
132.39, 128.30, 121.39, 120.09, 119.95, 119.17, 117.82, 112.33(Ar-C);
and 56.29(-OCH3). Found: C, 73.12; H, 5.89; N, 6.12 %. Cal. for
C14H13NO2: C, 73.99; H, 5.77; N, 6.16 %
2.2. Synthesis of the Complexes
0.114 g (0.573 mmol) of copper acetate monohydrate,
Cu(OAc)2.H2O, was dissolved in 10 mL ethanol and added
dropwisely to a vigorously stirring 0.30 g (1.15 mmol) ethanolic
solution of ligand L1. The resulting solution was refluxed for 6 h
to obtain a brown precipitate. It was filtered under suction,
washed thoroughly with ethanol and dried over silica gel in
a desiccator. The same procedure was repeated for all the
complexes. However, the addition of aqueous ammonia to L3/
Cu(OAc)2.H2O aliquot resulted in the hydrolysis of the imine
bond and consequent formation of an ammonia-based complex
as shown in Schemes 2 and 3. The same product was obtained
with ligand L4. The analytical and the spectral data for the com-
plexes are presented in Tables 1 and 2.
3. X-ray Crystallography Data
Single crystals of the [Cu(ovan-NH)2].H2O complex were
obtained via slow evaporation of the saturated DMF solution of
the complex. A suitable single crystal of the complex was diffracted
using a Bruker KAPPA APEX II single crystal x-ray diffrac-
tometer, with a 4-circle Kappa goniometer. The crystallographic
data was collected at 200 K and 0.7107 nm (lll) on a sensitive CCD
detector with graphite-monochromated MoK a radiation, a total
of 1978 reflections was collected of which 1836 were considered
observed [I > 2s(I)]. The structure was solved by direct method
using the program SHELXL-9728 and refined anisotropically by
full matrix least-squares on F2 using SHELXL-97. The details of
crystallographic parameters, data collection and refinements are
listed in Table 3 while selected bond lengths and angles are
presented in Table 4.
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Scheme 2 Hydrolosis of the Schiff base ligands.
Scheme 3 Formation of Cu(ovan-NH)2 from the hydrolysed Schiff base ligand.
Table 1 Physical and analytical data for the complexes.
Complexes Colour % Yield M. Pt/°C Molar mass % Found (calculated) LM
C H N Cu /W
–1 cm2 mol–1
[Cu(L1)2] * Brown 60 174–176 584.85 57.48 (57.50) 3.80 (3.79) 4.71 (4.79) 10.50 (10.87) 2.90
a DMF
[Cu(L2)2] Brown 68 172–174 673.91 49.97 (49.90) 3.36 (3.29) 4.12 (4.16) (9.57) (9.43) 6.59
a DMF
[Cu(ovan- Green 91 166–168 399.90 47.70 (48.06) 5.07 (5.04) 6.97 (7.01) 15.80 (15.89) 1.80 a DMF
NH)2].H2O
[Cu(L5)2] Brown 81 250–252 524.93 59.24 (59.49) 3.36 (3.46) 5.29 (5.34) 12.30 (12.10) 1.65
a DMF
[Cu(L6)2] Brown 76 248–249 613.83 51.92 (51.87) 2.83 (2.96) 4.51 (4.56) 10.60 (10.35) 1.59
a DMF
[Cu(L7)2] Green 91 230–232 484.09 70.52 (69.47) 5.11 (5.00) 5.73 (5.76) 12.30 (12.10) 2.71
a DMF
[Cu(L8)2] Brown 76 208–210 516.07 64.66 (65.16) 4.74 (4.69) 5.38 (5.43) 12.0 (12.31) 4.65
a DMF
*L1 = ovan-2-cla; L2 = ovan-2-bra; L5 = sal-2-cla; L6 = sal-2-bra; L7 = sal-2-tol; L8 = sal-2-nis. aNeutral complex
4. Results and Discussion
4.1. Elemental Analysis and Conductivity Measurement
The elemental analysis results for the complexes suggest that
the complexes are of the form CuL2, with the Cu
2+ ion coordinat-
ing to the Schiff base ligands in a ratio 1:2. The low conductivity
values for the complexes imply the Schiff base ligands coordinated
as neutral species29 via the deprotonated phenolic oxygen-O,
and the imine nitrogen-N, atoms.
4.2. 1H- and 13C- NMR
The assignments of the main NMR signals are given in the
experimental section. The azomethine proton (HC=N)
absorbed downfield in all the Schiff base ligands as one proton
singlet at 8.64–8.68 ppm while the broad signal at 13.82–
13.13 ppm is assigned to the phenolic hydroxyl proton. The
position of the hydroxyl signal is attributable to a strong
intramolecular hydrogen bonding through the imine -N and the
phenolic -O. The signal at 163.51–160.88 ppm is due to the imine
functional group (C=N), and further confirms the formation of
the Schiff base ligands. The purity of the ligands was, however,
indicated by the disappearance of the amino and aldehyde
protons at 3–4 ppm and 9–10 ppm, respectively. The methoxy
substituent of the o-vanillin analogues was observed as a strong
singlet at 3.99–3.97 ppm. In addition, the signals at 2.44 ppm and
3.93–3.88 ppm correspond to the methyl and methoxy substitu-
ents of the toluidine and anisidine-based ligands, respectively.
4.3. Infrared Study
The imine (C=N) functional group of the free ligands was
observed as a strong band at 1615–1612 cm–1. As expected, the
band red-shifted in the spectra of the complexes, except
[Cu(ovan-NH)2].H2O, indicating coordination of the Schiff base
ligands via the azomethine N-atom.24,26,30–31 In addition, the
strong band at 1280–1273 cm–1 corresponds to the phenolic C-O
stretching vibration of the free ligands. This band blue-shifted to
1336–1325 cm–1 upon complexation,5,31–32 suggesting the in-
volvement of the phenolic oxygen atom in the coordination
sphere. All the infrared spectra of the free ligands were charac-
terized by a broad band at 3220–2284 cm–1 corresponding to the
O-H stretching vibration of the ligands. The broadness was due
to a strong intramolecular hydrogen bonding between the imine
nitrogen and the hydroxyl group.33–34 The hydroxyl band, how-
ever, disappeared in the spectra of the complexes due to
deprotonation and involvement of the oxygen atom in the coor-
dination sphere. The mode of coordination of the Schiff base
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L1 3149–2365 1613 1277 – – 215, 227, 284, 320, 471
Cu(L1)2 – 1603 1336 559 464 236, 292, 403, 661
L2 3114–2370 1613 1277 – – 211, 228, 273, 325, 344
Cu(L2)2 – 1604 1331 561 460 235, 292, 404, 665
L3 3104–2349 1612 1277 – – 212, 225, 276, 320, 455
Cu(ovan-NH)2.H2O** 3413, 3294 1623 1331 541 482 237, 274, 378, 654
L4 3104–2344 1614 1280 – – 216, 229, 280, 346, 462
Cu(ovan-NH)2.H2O** 3413, 3294 1623 1331 541 482 237, 274, 378, 654
L5 3220–2359 1612 1273 – – 209, 227, 272, 324, 342
Cu(L5)2 – 1603 1325 556 455 213, 238, 398, 667
L6 3220–2359 1612 1277 – – 214, 227, 285, 319, 470
Cu(L6)2 – 1602 1325 556 466 226, 281, 393, 663
L7 3104–2334 1615 1279 – – 208, 224, 266,3 37, 442
Cu(L7)2 – 1606 1325 575 449 229, 373, 394, 657
L8 3084–2284 1615 1280 – – 205, 228, 268, 346, 450
Cu(L8)2 – 1606 1329 580 457 216, 283, 390, 683
**Cu(ovan-NH2)2.H2O was prepared using aqueous ammonia.
Table 3 Crystal data and structure refinements for the [Cu(ovan-
NH)2].H2O complex.





Space group P 21/c
a/Å 10.9309 (3)
b/Å 4.85600 (10)
c /Å 17.7030 (5)









Refinement method Full-matrix least squares of F2
Final R indices [F > 4s (F)] R1 = 0.0204, WR2 = 0.0574
R indices (all data) R1 = 0.0225, WR2 = 0.0593
Table 4 Selected bond lengths and bond angles for [Cu(ovan-NH)2].
H2O.
Bond lengths Å Bond angles °
Cu1-O1 1.9447(9) O1-Cu1-N1 92.19(5)
Cu1-N1 1.915(2) O1-Cu1-O1 180.00(4)
N1-H1 0.78(2) O1-Cu1-N1 87.81(5)
N1-C7 1.279(2) N1-Cu1-O1 87.81(5)
O1-C2 1.305(2) N1-Cu1-N1 180.00(6)
O2-C3 1.3729(2) O1-Cu1-N1 92.19(5)
O2-C8 1.423(2) O1–C2–C1 125.5(1)
O3-H3A 0.79(2) O1–C2–C3 118.2 (1)
O3-H3B 0.73(3)
ligand was further substantiated by the appearance of two new
bands in the far infrared spectra of the complexes at 580–541 cm–1
and 482–449 cm–1. These bands are assigned to the nCu-O and
nCu-N stretches, respectively.
4,5,33
Furthermore, the infrared spectrum of Cu(ovan-NH)2 has two
additional strong bands at 3413 cm–1 and 3294 cm–1. The bands
are attributed to the N-H stretching vibrations of ligand
ovan-NH that was obtained upon the addition of aqueous
ammonia to the aliquot of L3/L4 and Cu(OAc)2.H2O as shown in
Scheme 3.
4.4. UV/Visible Study
The electronic transition study of the compounds was carried
out in methanol. Three absorption bands were observed in the
spectra of the Schiff base ligands at 229–211 nm, 292–268 nm and
394–319 nm. The bands at higher energy values (229–211 nm) are
attributed to the p ® p* transition of the benzene ring 3 while the
other two bands are assigned to the p ® p* and n ® p* transi-
tions of the azomethine chromophore, respectively.3,12 These
transitions are observed at a lower energy values in the spectra
of the complexes, indicating coordination via the azomethine
functional group (HC=N).
The d ® d transition of the copper(II) ion was observed as a
broad band at 683–654 nm, indicating a square planar geometry.
Bhunora et al. observed similar band at 662–628 nm for a series of
square planar salicyaldiminecopper(II) complexes.26 The Schiff
base ligands showed an additional absorption band at above
400 nm (470–442 nm) in methanol, and this new band has been
previously assigned to the keto-imine form of ortho-hydroxy-
salicylaldimines in polar and non-polar solvents.3 The tautomer-
ism is thought to occur via an intramolecular (or intermolecular
in protonic solvents) hydrogen transfer to the imine nitrogen.
4.5. Molecular Structure of [Cu(ovan-NH)2].H2O
The labelled ORTEP diagram of [Cu(ovan-NH)2].H2O is pre-
sented in Fig. 1 while the bond lengths and angles are presented
in Table 4. The crystal structure consists of two units of the Schiff
base ligands chelating with the copper(II) ion in a planar milieu.
The copper(II) ion crystallizes in the monoclinic system with a
space group of P21/c having a = 10.9309, b = 4.85600,
c–= 17.7030, a= g = 90 ° and b = 119.658 °. The bidentate Schiff
base ligand formed a four coordinate chelate with the copper(II)
ion in a trans configuration through the imine nitrogen and the
phenolic oxygen atoms. The geometry is slightly distorted from
planarity with O1-Cu1-N1 bond angles of 92.19 ° and 87.8 °. The
bond lengths for the Cu–O (1.9447Å) and Cu–N (1.915 Å) fall
within the range of reported values for similar structures in the
literature (1.999 and 1.869; 1.8959 and 1.9769; 1.901 and
1.9769)Å.26 The structures reported by Bhunora et al.,26 equally
have the copper(II) ion in a planar geometry within the trans
configuration of the N2O2 donor atoms. In addition, there exist
intra-molecular hydrogen bonding with average bond length
(O–H) 0.76 Å (Fig. 2), occasioned by the presence of a water mole-
cule in the crystal lattice of the complex.
5. Biological Study
The Schiff base ligands and their respective copper(II)
complexes were screened for their in vitro antibacterial and
antifungal activity against Escherichia coli ATCC® 8739™*, Staphy-
lococcus aureus subsp. aureus ATCC® 6538™*, Bacillus subtilis
subsp. spizizenii ATCC® 6633™* and Candida albicans ATCC®
2091™*.
5.1. Disc Diffusion Technique
The qualitative antimicrobial susceptibility testing of the
compounds was evaluated using the disc diffusion technique.34
Each test organism was inoculated onto a nutrient agar plate and
incubated at 37 °C for 24 h to obtain the primary culture. Several
discrete colonies were picked from the culture to make a bacterial
suspension (10 mL) in a test tube using saline water. The turbidity
of the suspension was compared with 0.5 McFarland standard to
obtain 106–108 CFUs. The bacterial suspension (0.1 mL) was
inoculated onto Mueller Hinton plate and the sterile discs that
have been impregnated with the test compounds were firmly
placed on it. The assay was inoculated at 37 °C for 16 h and the
zone of inhibition was measured as millimetres diameter.
Ampicillin was used as the standard antibacterial drug while the
control solvent was dimethylformamide (DMF). The test was
repeated two more times for those compounds that showed
activity of more than 6.5 mm, and their activity was recorded
as average zone of inhibition in Table 5. Similar procedure was
repeated for the antifungal susceptibility testing of the com-
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Figure 1 ORTEP diagram for [Cu(ovan-NH)2].H2O with limited labelling for clarity, showing 50 % probability ellipsoids.
pounds using the potato disc assay instead of Mueller Hinton
agar. The standard antifungal drug used for the study was
ketoconazole.
5.2. Minimum Inhibitory Concentration (MIC)
The quantitative antimicrobial activity of the test compounds
was evaluated using micro dilution broth method according to
Clinical and Laboratory Standard Institute (formally NCCLS).34
Two-fold serial dilutions of the compounds were prepared in 96
microwell plates using sterile nutrient broth as the diluent. The
plates were inoculated with 5 µL bacterial suspensions
containing 106–108 CFUs and incubated at 37 °C for 16–18 h. The
MIC value was defined as the lowest concentration of the
compounds giving complete inhibition of visible growth. The
MIC values for the compounds varied from 6.250–0.1953 mg/mL
and the result is presented in Table 6.
The diameters of the zone of inhibition and the minimum
inhibitory concentrations (MIC) of the compounds are presented
in Tables 5 and 6, respectively. The compounds were not as active
as penicillin, but showed significant antifungal activity against
the tested organisms.
The o-vanillin-based ligands exhibited higher activity than the
salicylaldehyde-based compounds which were virtually
non-active against the tested organisms. This could be due to the
presence of the methoxy group at the ortho position of the alde-
hyde moiety of the Schiff base ligands. Likewise, ligands L3
and L4 (toluidine and anisidine derivatives) showed significant
potency against the microorganisms (Fig. 3); thus relating the
activity of the Schiff bases to the electronic effects of the substitu-
ents, since the chloro- and the bromo- analogues exhibited only
slight activity. Ansari et al.35 has, however, reported high
antimicrobial activity for the o-chloro, o-methyl, o-methoxyl and
p-amino analogues in a series of substituted benzimidazole
Schiff base ligands.
On chelation, however, the presence of the Cu(II) ions did not
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Figure 2 Chains of hydrogen bonding in the crystal lattice of [Cu(ovan-NH)2].H2O viewed along the b-axis.
Table 5 Diameters of zone of inhibition (mm) for the Schiff base ligands
and the complexes.
No. Compounds Gram- Gram- Fungus
positive negative
S. aureus B. substilis E. coli C. albicans
1 L1 (ovan-2-cla) 12 – 8.5 20
2 Cu(L1)2 – – – 16
3 L2 (ovan-2-bra) 12 – 09 21
4 Cu(L2)2 – 08 07 16
5 L3 (ovan-2-tol) 11.5 10 16 26
6 [Cu(ovan-NH)2] ns* ns* ns* ns*
7 L4 (ovan-2-nis) 16 16 14 44
8 [Cu(ovan-NH)2] ns* ns* ns* ns*
9 L5 (sal-2-cla) – 08 – 08
10 Cu(L5) ns* ns* ns* ns*
11 LVI (sal-2-bra) – 08 – –
12 Cu(L
6) ns* ns* ns* ns*
13 L7 (sal-2-tol) – 08 08 07
14 Cu(L7) – – – –
15 L8 (sal-2-nis) – 09 – 07
16 Cu(L8) 07 – 08 16
Ampicillin 52 38 28
Ketoconazole 20
DMF – – – –
Note: disc diameter is 6.5 mm; *ns: not soluble; (–): not active.
Table 6 MIC values for the Schiff base ligands and the complexes (1 ×
10–1 mg/mL).
No. Compounds Gram-positive Gram-negative
S. aureus B. substilis E.coli
1 L1 1.9531 (12) – 1.9531 (8.5)
2 L2 7.8125 (12) – 7.8125 (09)
3 CuL2 – 7.8125 (08) 62.50 (07)
4 L3 3.9063 (11.5) 7.8125 (10) 1.9531 (16)
5 L4 3.9063 (16) 3.9063 (16) 3.906 (14)
6 L5 – 31.25 (08) –
7 LVI – 31.25 (08) –
8 LVII – 15.625 (08) 7.8125 (08)
9 LVIII – 15.625 (09) –
10 Cu(LVIII)2 31.250 (07) – 31.250 (08)
Note: the diameter of zone of inhibition is given in brackets.
enhance the antimicrobial activity of the free ligands. The copper
complexes exhibited lower activity than the Schiff base ligands.
Though, it is believed that chelation increases the lipophilicity of
the metal ion and consequently increases the antimicrobial
activity of metal complexes relative to the free ligands. Con-
versely, it has been observed that the free ligands do possess
higher activity in some cases; an indication that activity does not
depend solely on the presence of metal ions but rather a syner-
gistic effect of many factors. Thus, understanding the mecha-
nisms of action of potential antimicrobial agent is considered a
critical aspect of our study for the future.
6. Conclusion
The ortho-substituted Schiff bases coordinated as monobasic
bidentate ligands via the imine nitrogen and phenolic oxygen
atoms. The crystal structure of bis(3-methoxyl-2-methylimine)
copper(II) complex, indicated a planar configuration for the
complexes. The antimicrobial study of the compounds revealed
higher activity for the o-vanillin derivatives than the salicylalde-
hyde-based ligands.
7. Supplementary Data
X-ray crystallography data of bis(3-methoxy((imine)methyl-
phenol)Cu(II) complex has been deposited with the Cambridge
Crystallographic Data Centre (CCDC) and can be obtained free
of charge on request at http://www.ccdc.cam.ac.uk/conts/
retrieving.html or from the Cambridge Crystallographic Data
Centre (CCDC), 12 Union Road, Cambridge CB2 1EZ, UK; fax:
+44(0)1223-336033; e-mail: deposit@ccdc.cam.ac.uk, quoting
the CCDC number, 888472.
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Figure 3 Antimicrobial activity of the o-vanillin derivatives of the Schiff
base ligands.
